Our Mission 2018-08-16T18:56:50+00:00

Our Mission

AMDR’s mission is to protect the trade interests of the global commercial reprocessing industry and promote reprocessing as a healthcare strategy that increases quality, reduces costs and improves patient care.

CREDO

WHO WE ARE

AMDR is the global trade association consisting of members of the commercial single‐use
device reprocessing and remanufacturing industry. AMDR represents commercial reprocessing,
promotes reprocessing as an important healthcare strategy that helps hospitals and healthcare
providers increase quality, reduce costs and improve patient care, and protects the interests of
its members in regulation, legislation and standard‐setting world‐wide.

Having played a key role in the establishment of the reprocessing industry, AMDR continues to push the medical technology industry and lead the way for reprocessing to play a defining role in the evolution and utilization of new technologies.

OUR RESPONSIBILITY

Our paramount responsibility is to healthcare institutions, including the hospitals and clinicians
that strive to provide the best care possible to all patients. To meet this responsibility, AMDR
works to better align the medical device industry with the fundamental interests of hospitals
and healthcare providers by making single‐use device reprocessing and remanufacturing a key
supply chain strategy for all hospitals.

THE ROLE OF REPROCESSING

Single‐use medical device reprocessing plays a crucial in role in helping hospitals achieve the
triple aim of increasing quality, reducing costs and improving patient care.  Use of regulated
reprocessed SUDs ensures the highest possible quality, and lowers overall cost per device use,
thereby enabling hospitals to access new technologies and serve a growing patient population.

Further, single‐use device reprocessing is one of the most effective healthcare sustainability
strategies available to hospitals and healthcare providers. It is a strategy that simultaneously
reduces the environmental impact from discarding used medical devices, enables hospitals to
enhance their financial sustainability, and allows hospitals and healthcare providers to
positively contribute to environmental sustainability.

WHAT THE FUTURE HOLDS

We believe that the use of reprocessed medical devices should be maximized in all hospitals
and healthcare facilities, and we are committed to growing reprocessing in terms of volume as
well as scope so that healthcare can continue to increase the responsible and safe reuse of
medical devices.

We believe that the future of healthcare requires the medical device industry to enter into a
new paradigm where the focus is on providing value to healthcare rather than pursuing one‐
sided profit goals. This means that reprocessing should be an integrated element in medical
device technology development and marketing.

You can find more about AMDR’s  Code of Conduct here.

The Association of Medical Device Reprocessors (AMDR) serves as the trade association for third-party reprocessors of “single-use” medical devices. Based in Washington, DC, AMDR advocates on behalf of industry trade interests, which include, but are not limited to:

  • The proper reprocessing of medical devices labeled by the original equipment manufacturer for “single-use;”
  • Reprocessed devices that are as safe and effective as original devices;
  • Reprocessing as a means of cutting healthcare costs while maintaining patient safety and quality of care;
  • Third-party reprocessing as an environmentally responsible practice;
  • The highest possible standards of regulatory and professional conduct by its members;
  • A forum for reprocessing issues; and
  • Education for healthcare providers, government officials, patients and the media about reprocessing issues.

Definition of Third-Party Reprocessor: Any FDA-regulated entity that, at the request of a provider customer, inspects, refurbishes, function tests, cleans, packages, and sterilizes medical devices labeled as “single-use” in such a manner that:

  • The quality, physical characteristics, and functionality of the devices are not adversely affected, or such characteristics are improved;
  • The devices remain safe and effective for an additional single-use; and
  • The devices are reprocessed in full compliance with FDA regulations.